MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort

被引：75

作者：

Han, Hui ^{[1
]}

Qu, Guangjin ^{[1
]}

Han, Chenghua ^{[2
]}

Wang, Yuhong ^{[1
]}

Sun, Tingting ^{[1
]}

Li, Fengqing ^{[1
]}

Wang, Junxiao ^{[1
]}

Luo, Shanshun ^{[1
]}

机构：

[1] Harbin Med Univ, Hosp 1, Dept Gerontol, Harbin 150001, Heilongjiang Pr, Peoples R China

[2] Harbin Med Univ, Dept Nat Prod Chem, Daqing, Peoples R China

来源：

EXPERIMENTAL AND MOLECULAR MEDICINE | 2015年 / 47卷

基金：

中国国家自然科学基金;

关键词：

MICRORNA EXPRESSION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; HUMAN HEART; CANCER; MICE; SERUM; ATHEROSCLEROSIS; OVEREXPRESSION; ANGIOGENESIS;

D O I：

10.1038/emm.2014.81

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The aim of this study was to investigate the expression of circulating microRNAs (miRNAs) in apolipoprotein E (apoE) knockout mice (apoE(-/-)) and to validate the role of these miRNAs in human coronary artery disease (CAD). Pooled plasma from 10 apoE(-/-) mice and 10 healthy C57BL/6 (B6) mice was used to perform the microarray analysis. The results showed that miR-34a, miR-21, miR-23a, miR-30a and miR-106b were differentially expressed in apoE(-/-) mice, and these expression changes were confirmed by real-time quantitative reverse-transcription PCR. Then, miR-34a, miR-21, miR-23a, miR-30a and miR-106b were detected in the plasma of 32 patients with CAD and of 20 healthy controls. Only miR-34a, miR-21 and miR-23a were significantly differentially expressed in the plasma of CAD patients (all P<0.01). In conclusion, miR-34a, miR-21 and miR-23a were elevated in CAD patients, which means that these miRNAs might serve as biomarkers of CAD development and progression.

引用

页码：e138 / e138

页数：7

共 59 条

[1] Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages
Aiello, RJ
Brees, D
Bourassa, PA
Royer, L
Lindsey, S
Coskran, T
Haghpassand, M
Francone, OL
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) : 630 - 637
[2] miR-34a Regulates Mouse Neural Stem Cell Differentiation
Aranha, Marcia M.
Santos, Daniela M.
Sola, Susana
Steer, Clifford J.
Rodrigues, Cecilia M. P.
[J]. PLOS ONE, 2011, 6 (08):
[3] Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets
Artmann, Stephan
Jung, Klaus
Bleckmann, Annalen
Beissbarth, Tim
[J]. PLOS ONE, 2012, 7 (06):
[4] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
Bartel, David P.
[J]. CELL, 2007, 131 (04) : 11 - 29
[5] Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering
Bea, F
Blessing, E
Bennett, B
Levitz, M
Wallace, EP
Rosenfeld, ME
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) : 1832 - 1837
[6] bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila
Brennecke, J
Hipfner, DR
Stark, A
Russell, RB
Cohen, SM
[J]. CELL, 2003, 113 (01) : 25 - 36
[7] MicroRNAs Expression Profiles in Cardiovascular Diseases
Bronze-da-Rocha, Elsa
[J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[8] MicroRNA profiling in early hypertrophic growth of the left ventricle in rats
Busk, Peter K.
Cirera, Susanna
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (04) : 989 - 993
[9] microRNAs in vertebrate physiology and human disease
Chang, Tsung-Cheng
Mendell, Joshua T.
[J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2007, 8 : 215 - 239
[10] MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages
Chen, Ting
Huang, Zhouqing
Wang, Liansheng
Wang, Yue
Wu, Feizhen
Meng, Shu
Wang, Changqian
[J]. CARDIOVASCULAR RESEARCH, 2009, 83 (01) : 131 - 139

← 1 2 3 4 5 6 →